| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $908.3M | -6.9% |
| Cost of Revenue | $719.0M | -7.2% |
| R&D Expense | $72.2M | +1.5% |
| SG&A Expense | $117.5M | +0.1% |
| Operating Income | -$381K | -103.0% |
| Pre-tax Income | -$13.6M | -607.4% |
| Income Tax | $2.9M | -10.2% |
| Net Income | -$16.5M | -218.8% |
| EPS (Basic) | -$0.60 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.8M | +75.9% |
| Accounts Receivable | $137.8M | -17.3% |
| Inventory | $151.3M | -19.4% |
| Current Assets | $387.5M | -9.8% |
| Total Assets | $621.6M | -8.6% |
| Current Liabilities | $150.0M | -15.9% |
| Long-term Debt | $201.6M | +5.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.7M | +865.4% |
| Investing Cash Flow | -$24.5M | +33.8% |
| Financing Cash Flow | $11.1M | -36.4% |
| -215.8% |
| EPS (Diluted) | -$0.60 | -215.8% |
| Stockholders' Equity |
| $245.3M |
| -14.8% |